
|Podcasts|September 2, 2020
Joshua Denson, MD: Impact of Metabolic Syndrome in COVID-19 Patients
Author(s)Patrick Campbell
A podcast featuring the lead investigator of a recent study examining impact of metabolic syndrome on COVID-19 outcomes in a pair of New Orleans-based hospitals.
Advertisement
In this episode of the Endocrine Outlook, you will hear from Dr. Joshua Denson of Tulane University Medicine. In the episode, we discuss the results of
Results of the study suggest individual components on metabolic syndrome were not associated with worse outcomes but their combined presence in the form of metabolic syndrome resulted in more severe outcomes among their patient population.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
3
High-Dose Semaglutide Preserves Kidney Function, Reduces Inflammation in Obesity Without Diabetes
4
Machine Learning Model Predicts Type 2 Diabetes Risk Up To 10 Years Out
5


























































